Related Experiment Video
Updated: Aug 7, 2026

An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function
Published on: May 4, 2021
APPLied mechanics: uncovering how adiponectin modulates insulin action
Sarah E Hosch1, Jerrold M Olefsky, Jane J Kim
1Department of Medicine, University of California, San Diego, La Jolla, California 92093, USA.
Adiponectin hormone is linked to insulin resistance. The APPL1 protein acts as a bridge, connecting adiponectin receptors to insulin sensitization pathways, revealing a new mechanism for metabolic health.
Area of Science:
- Endocrinology
- Molecular Biology
- Metabolic Research
Background:
- Adiponectin, an adipocyte hormone, is implicated in insulin resistance associated with metabolic syndrome and diabetes.
- Understanding the molecular mechanisms linking adiponectin to insulin sensitivity is crucial for developing therapeutic strategies.
Purpose of the Study:
- To investigate the role of the APPL1 adaptor protein in mediating adiponectin's effects.
- To elucidate a novel mechanism connecting adiponectin signaling to insulin sensitization.
Main Methods:
- The study focused on the interaction between APPL1 and adiponectin receptors.
- Investigated the functional consequences of this interaction on insulin signaling pathways.
Main Results:
- The APPL1 adaptor protein was found to bind to the intracellular domain of adiponectin receptors.
- This interaction mediates key actions of adiponectin, contributing to insulin sensitization.
Conclusions:
- APPL1 represents a novel link between adiponectin and insulin sensitization.
- This discovery provides a new molecular target for addressing insulin resistance and related metabolic disorders.
Related Concept Videos
Insulin: The Receptor and Signaling Pathways
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are co-secreted in...
Type II Diabetes II: Pathophysiology
